Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Condensed Consolidated Statements of Operations (Unaudited)        
Revenues $ 0 $ 0 $ 0 $ 0
Operating Expenses:        
Research and development 1,008,000 84,000 3,287,000 252,000
Selling, general and administrative (including $577,000 and $15,450,000 of stock compensation to officers and directors in 2021 during the three and nine months ended September 30, 2021) 4,946,000 2,029,000 36,050,000 4,321,000
Loss from Operations 5,954,000 1,945,000 39,337,000 4,573,000
Other (Income) Expense        
Interest income (32,000)   (32,000)  
Unrealized loss on marketable securities 33,000   33,000  
Change in fair value of derivative liability (502,000) 0 (43,000) 0
Settlement expense 0 0 0 11,206,000
Interest expense 0 931,000 696,000 6,227,000
Total Other Expense, net (501,000) 931,000 654,000 17,433,000
Net Loss $ (5,453,000) $ (2,876,000) $ (39,991,000) $ (22,006,000)
Net loss per share - basic and diluted $ (0.17) $ (0.64) $ (1.54) $ (5.13)
Weighted average common shares outstanding - basic and diluted 31,381,282 4,513,534 25,945,827 4,288,808